NCT05138289View on ClinicalTrials.gov

The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA

CompletedOBSERVATIONAL
Enrollment

258

Participants

Timeline

Start Date

October 12, 2021

Primary Completion Date

November 8, 2022

Study Completion Date

November 8, 2022

Conditions
Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Interventions
OTHER

Total Plaque Volume

Compare total plaque volume with IVUS obtained during ICA (invasive coronary angiography)

Trial Locations (1)

68506

HeartFlow Investigative Site, Lincoln

Sponsors

Lead Sponsor

HeartFlow, Inc.
All Listed Sponsors
lead

HeartFlow, Inc.

INDUSTRY